Antibody-dependent enhancement of Coronavirus

Vista sencilla de ítem
dc.creatorWen, Jieqi
dc.creatorCheng, Yifan
dc.creatorLing, Rongsong
dc.creatorDai, Yarong
dc.creatorHuang, Boxuan
dc.creatorHuang, Wenjie
dc.creatorZhang, Siyan
dc.creatorJiang, Yizhou
dc.date.accessioned2020-09-18T00:52:57Z
dc.date.available2020-09-18T00:52:57Z
dc.date.created2020-09-11
dc.description.abstractenglishAntibody-dependent enhancement (ADE) exists in several kinds of virus. It has a negative influence on antibody therapy for viral infection. This effect was first identified in dengue virus and then was also described for coronavirus. The rapid spread of the newly emerged 2019 novel coronavirus (COVID-19) has sickened over 3.8 million people across the globe up to now. The novel coronavirus causes great challenge and arouses a wave of panic. In this review, antibody-dependent enhancements in dengue virus and two kinds of coronavirus are summarized. Solutions for the effects are mentioned, too. We also speculate that antibody-dependent enhancement may exist in COVID-19.spa
dc.format.extent21 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.1016/j.ijid.2020.09.015spa
dc.identifier.issn1201-9712spa
dc.identifier.otherhttps://www.sciencedirect.com/science/article/pii/S1201971220307311spa
dc.identifier.urihttps://hdl.handle.net/20.500.12010/13409
dc.language.isoengspa
dc.publisherInternational Journal of Infectious Diseasesspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.localAbierto (Texto Completo)spa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subject.keywordAntibody-dependent enhancement (ADE)spa
dc.subject.keyword2019 novel coronavirus (COVID-19)spa
dc.subject.keywordSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)spa
dc.subject.keywordSevere acute respiratory syndrome coronavirus (SARS-CoV)spa
dc.subject.keywordMiddle East respiratory syndrome coronavirus (MERS-CoV)spa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.titleAntibody-dependent enhancement of Coronavirusspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localArtículospa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
Antibody-dependent-enhancement-of-Co_2020_International-Journal-of-Infectiou.pdf
Tamaño:
2.04 MB
Formato:
Adobe Portable Document Format
Descripción:
Ver documento
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
2.87 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Documentos científicos relacionados a la COVID-19

Carrera 4 # 22-61 Teléfono: (+57) 601 242 7030 - 018000111022 Fax: (+57) 601 561 2107 Bogotá D.C., Colombia

Fundación Universitaria de Bogotá Jorge Tadeo Lozano | Vigilada Mineducación

Institución de educación superior privada, de utilidad común, sin ánimo de lucro y su carácter académico es el de Universidad

Reconocimiento personería jurídica: Resolución 2613 del 14 de agosto de 1959 Minjusticia.

Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

Software DSpace copyright © 2002-2026 LYRASIS